Instrumento Inactivo

Otros idiomas SYNTH MR Swiss Exchange

Acciones

SE0005454865

Precio de cierre Swiss Exchange Otros sitios de cotización
- ^SEK	-

22/05	SyntheticMR AB (publ) anuncia cambios en la Junta Directiva	CI
21/05	SyntheticMR AB (publ) proporciona orientación de ganancias para el año 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Report from Annual General Meeting in SyntheticMR AB (publ)	22/05
SyntheticMR AB Announces Board Changes	22/05
Interim report January - March 2024	21/05
SyntheticMR AB Provides Earnings Guidance for the Year 2024	21/05
SyntheticMR AB Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05
Notice to attend the annual general meeting of SyntheticMR AB (publ)	19/04
SyntheticMR publishes annual report for 2023	19/04
SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities.	17/04
SyntheticMR AB and SimonMed Imaging Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from Synthetic Software at SimonMed Facilities	17/04
SyntheticMR : and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities	17/04
SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D	27/03
SyntheticMR Receives FDA 510(k) Clearance for Their Next Generation Solution SyMRI 3D	27/03
Decided allocation regarding incentive program LTIP 2024 and TO 2	12/03
Fixed subscription price for warrants of series TO 2 and TO 3	05/03
Philips teams with Synthetic MR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients at ECR2024	01/03
Royal Philips Partners SyntheticMR to Roll Out New Brain Disorder Diagnosis Technology	01/03
Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients	01/03
Subscription price for shares in the incentive program LTIP 2024	27/02
Report from the extraordinary general meeting in SyntheticMR AB (publ)	20/02
Year-End report January - December 2023	20/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas SYNTH MR Swiss Exchange

Acciones

SE0005454865

Otros idiomas

Filtros